Liposomes as colloidal nanovehicles: on the road to success in intravenous drug delivery

References

Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol 1984; 2: 283–318.10.1146/annurev.iy.02.040184.001435Search in Google Scholar PubMed

Agarwal R, Iezhitsa I, Agarwal P, Abdul Nasir NA, Razali N, Alyautdin R, Ismail NM. Liposomes in topical ophthalmic drug delivery: an update. Drug Deliv 2016; 23: 1075–1091.10.3109/10717544.2014.943336Search in Google Scholar PubMed

Ahmad A, Mondal SK, Mukhopadhyay D, Banerjee R, Alkharfy KM. Development of liposomal formulation for delivering anticancer drug to breast cancer stem cell-like cells and its pharmacokinetics in an animal model. Mol Pharm 2016; 13: 1081–1088.10.1021/acs.molpharmaceut.5b00900Search in Google Scholar PubMed

Ahmed M, Monsky WE, Girnun G, Lukyanov A, D’Ippolito G, Kruskal JB, Stuart KE, Torchilin VP, Goldberg SN. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res 2003; 63: 6327–6333.Search in Google Scholar

Ahmed M, Liu Z, Lukyanov AN, Signoretti S, Horkan C, Monsky WL, Torchilin VP, Goldberg SN. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals 1. Radiology 2005; 235: 469–477.10.1148/radiol.2352031856Search in Google Scholar PubMed

Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Nejati-Koshki K. Liposome: classification, preparation, and applications. Nanoscale Res Lett 2013; 8: 102.10.1186/1556-276X-8-102Search in Google Scholar PubMed PubMed Central

Akhtari J, Rezayat SM, Teymouri M, Alavizadeh SH, Gheybi F, Badiee A, Jaafari MR. Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using balb/c mice bearing tubo tumors. Int J Pharm 2016; 505: 89–95.10.1016/j.ijpharm.2016.03.060Search in Google Scholar PubMed

Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013; 65: 36–48.10.1016/j.addr.2012.09.037Search in Google Scholar PubMed

Anders CK, Adamo B, Karginova O, Deal AM, Rawal S, Darr D, Schorzman A, Santos C, Bash R, Kafri T. Pharmacokinetics and efficacy of pegylated liposomal doxorubicin in an intracranial model of breast cancer. PLoS One 2013; 8: e61359.10.1371/journal.pone.0061359Search in Google Scholar PubMed PubMed Central

Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter, P. Molecular Biology of the Cell, 4th ed,, New York: Garland Science, 2002. The Lipid Bilayer. Available from: http://www.ncbi.nlm.nih.gov/books/NBK26871/figure/Search in Google Scholar

Azadi A, Ashrafi H. Cell organelle-shaped liposomes: a novel approach to present the stable intracellular drug delivery systems. Trends Pharm Sci 2016; 2: 85–88.Search in Google Scholar

Bagalkot V, Deiuliis JA, Rajagopalan S, Maiseyeu A. “Eat me” imaging and therapy. Adv Drug Deliv Rev 2016; 99: 2–11.10.1016/j.addr.2016.01.009Search in Google Scholar PubMed PubMed Central

Bansal R. Methods and compositions of inhibiting complement and cellular activation with dextran sulfate. Google Patents, 2015.Search in Google Scholar

Barenholz YC. Doxil®—the first FDA-approved nano-drug: from basics via CMC, cell culture and animal studies to clinical use. Nanomedicines 2016; 315–345.10.1039/9781782622536-00315Search in Google Scholar

Bender EA, Adorne MD, Colomé LM, Abdalla DS, Guterres SS, Pohlmann AR. Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int J Pharm 2012; 426: 271–279.10.1016/j.ijpharm.2012.01.051Search in Google Scholar PubMed

Bigdeli A, Palchetti S, Pozzi D, Hormozi-Nezhad MR, Baldelli Bombelli F, Caracciolo G, Mahmoudi M. Exploring cellular interactions of liposomes using protein corona fingerprints and physicochemical properties. ACS Nano 2016; 10: 3723–3737.10.1021/acsnano.6b00261Search in Google Scholar PubMed

Bisht S, Schlesinger M, Rupp A, Schubert R, Nolting J, Wenzel J, Holdenrieder S, Brossart P, Bendas G, Feldmann G. A liposomal formulation of the synthetic curcumin analog ef24 (lipo-ef24) inhibits pancreatic cancer progression: towards future combination therapies. J Nanobiotechnology 2016; 14: 1.10.1186/s12951-016-0209-6Search in Google Scholar PubMed PubMed Central

Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine 2015; 10: 975.10.2147/IJN.S68861Search in Google Scholar PubMed PubMed Central

Caceres S, Peña L, Lacerda L, Illera M, Andres P, Larson R, Gao H, Debeb B, Woodward W, Reuben J. Canine cell line, ipc‐366, as a good model for the study of inflammatory breast cancer. Vet Comp Oncol 2016: 1–16, DOI: 10.1111/vco.12238.10.1111/vco.12238Search in Google Scholar PubMed

Camacho KM, Menegatti S, Vogus DR, Pusuluri A, Fuchs Z, Jarvis M, Zakrewsky M, Evans MA, Chen R, Mitragotri S. Dafodil: a novel liposome-encapsulated synergistic combination of doxorubicin and 5fu for low dose chemotherapy. J Control Release 2016; 229: 154–162.10.1016/j.jconrel.2016.03.027Search in Google Scholar PubMed PubMed Central

Comba S, Sethi R. Stabilization of highly concentrated suspensions of iron nanoparticles using shear-thinning gels of xanthan gum. Water Res 2009; 43: 3717–3726.10.1016/j.watres.2009.05.046Search in Google Scholar PubMed

da Silva CB, Groppo FC, dos Santos CP, Serpe L, Franz-Montan M, de Paula E, Ranali J, Volpato MC. Anaesthetic efficacy of unilamellar and multilamellar liposomal formulations of articaine in inflamed and uninflamed tissue. Br J Oral Maxillofac Surg 2016; 54: 295–300.10.1016/j.bjoms.2016.01.005Search in Google Scholar PubMed

Dai W, Yang F, Ma L, Fan Y, He B, He Q, Wang X, Zhang H, Zhang Q. Combined motor inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer. Biomaterials 2014; 35: 5347–5358.10.1016/j.biomaterials.2014.03.036Search in Google Scholar PubMed

Danenberg HD, Fishbein I, Gao J, Mönkkönen J, Reich R, Gati I, Moerman E, Golomb G. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 2002; 106: 599–605.10.1161/01.CIR.0000023532.98469.48Search in Google Scholar

Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol 2016; 44: 381–391.10.3109/21691401.2014.953633Search in Google Scholar PubMed

Ding B-S, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. Advanced drug delivery systems that target the vascular endothelium. Mol Interv 2006; 6: 98.10.1124/mi.6.2.7Search in Google Scholar PubMed

Dobrovolskaia MA, McNeil SE. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 2013; 172: 456–466.10.1016/j.jconrel.2013.05.025Search in Google Scholar PubMed PubMed Central

Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA, Marquis RW. Mlkl compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014; 7: 971–981.10.1016/j.celrep.2014.04.026Search in Google Scholar PubMed

Duehrkop C, Leneweit G, Heyder C, Fromell K, Edwards K, Ekdahl KN, Nilsson B. Development and characterization of an innovative heparin coating to stabilize and protect liposomes against adverse immune reactions. Colloids Surf B Biointerfaces 2016; 141: 576–583.10.1016/j.colsurfb.2016.02.014Search in Google Scholar PubMed

Durymanov MO, Yarutkin AV, Bagrov DV, Klinov DV, Kedrov AV, Chemeris NK, Rosenkranz AA, Sobolev AS. Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration. J Control Release 2016; 232: 20–28.10.1016/j.jconrel.2016.04.011Search in Google Scholar PubMed

Edwards KA. Analytical utility of liposomes: from past to present. Liposomes in Analytical Methodologies 2016; 1. Singapore: Pan Stanford Publishing Pte. Ltd. ISBN 978-981-4669-26-9 (Hardcover), 978-981-4669-27-6 (eBook) www. panstanford.com.10.1201/b19912Search in Google Scholar

Elmowafy M, Viitala T, Ibrahim HM, Abu-Elyazid SK, Samy A, Kassem A, Yliperttula M. Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and hepg2 drug uptake. Eur J Pharm Sci 2013; 50: 161–171.10.1016/j.ejps.2013.06.012Search in Google Scholar PubMed

Esposito S, Colicchia S, Torre X, Donati F, Mazzarino M, Botrè F. Liposomes as potential masking agents in sport doping. Part 2: Detection of liposome‐entrapped haemoglobin by flow cytofluorimetry. Drug Test Anal 2017; 9: 208–215.10.1002/dta.1956Search in Google Scholar PubMed

Feng L, Gao M, Tao D, Chen Q, Wang H, Dong Z, Chen M, Liu Z. Cisplatin‐prodrug‐constructed liposomes as a versatile theranostic nanoplatform for bimodal imaging guided combination cancer therapy. Adv Funct Mater 2016; 26: 2207–2217.10.1002/adfm.201504899Search in Google Scholar

Filipović M, Lukić M, Krstonošić V, Đorđević S, Pantelić I, Gledović A, Vuleta G, Savić S. Feasibility of a natural surfactant as a stabilizer for cosmetics with liposome-encapsulated plant stem cells: pre-formulation and formulation through stability studies. Tenside Surfact Det 2016; 53: 214–226.10.3139/113.110426Search in Google Scholar

Finn RS, Dering J, Ginther C, Wilson CA, Glaspy P, Tchekmedyian N, Slamon DJ. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro. Breast Cancer Res Treat 2007; 105: 319–326.10.1007/s10549-006-9463-xSearch in Google Scholar PubMed

Forbes GB. Human Body Composition: Growth, Aging, Nutrition, and Activity. Springer Science & Business Media 2012.Search in Google Scholar

Fox CB, Moutaftsi M, Vergara J, Desbien AL, Nana GI, Vedvick TS, Coler RN, Reed SG. Tlr4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses. Vaccine 2013; 31: 5848–5855.10.1016/j.vaccine.2013.09.069Search in Google Scholar PubMed

Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 2012; 7: 5577–5591.10.2147/IJN.S36111Search in Google Scholar PubMed PubMed Central

Gey G, Coffman W, Kubicek MT. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952; 12: 264–265.Search in Google Scholar

Giovinazzo H, Kumar P, Sheikh A, Brooks KM, Ivanovic M, Walsh M, Caron WP, Kowalsky RJ, Song G, Whitlow A. Technetium tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of pegylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemother Pharmacol 2016; 77: 565–573.10.1007/s00280-015-2945-ySearch in Google Scholar PubMed

Gref R, Domb A, Quellec P, Blunk T, Müller R, Verbavatz J, Langer R. The controlled intravenous delivery of drugs using peg-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 2012; 64: 316–326.10.1016/j.addr.2012.09.008Search in Google Scholar

Guo P, Yang J, Di Jia MAM, Auguste DT. Icam-1-targeted, lcn2 sirna-encapsulating liposomes are potent anti-angiogenic agents for triple negative breast cancer. Theranostics 2016; 6: 1.10.7150/thno.12167Search in Google Scholar PubMed PubMed Central

Hagisawa K, Nishioka T, Suzuki R, Takizawa T, Maruyama K, Takase B, Ishihara M, Kurita A, Yoshimoto N, Ohsuzu F. Enhancement of ultrasonic thrombus imaging using novel liposomal bubbles targeting activated platelet glycoprotein iib/iiia complex–in vitro and in vivo study. Int J Cardiol 2011; 152: 202–206.10.1016/j.ijcard.2010.07.016Search in Google Scholar PubMed

Han HD, Jeon YW, Kwon HJ, Jeon HN, Byeon Y, Lee CO, Cho SH, Shin BC. Therapeutic efficacy of doxorubicin delivery by a co 2 generating liposomal platform in breast carcinoma. Acta Biomater 2015; 24: 279–285.10.1016/j.actbio.2015.06.019Search in Google Scholar PubMed

Hanke W. (1978). The adrenal cortex of Amphibia. General, comparative and clinical endocrinology of the adrenal cortex. Academic press INC, London 1978; 2: 419–495.10.1016/B978-0-12-171502-1.50012-5Search in Google Scholar

Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A, Vanninen E, Mussalo H, Kauppila E, Simula S. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677–2683.10.1161/01.CIR.0000070540.80780.92Search in Google Scholar

Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res 2011a; 13: 1.10.1186/bcr2889Search in Google Scholar

Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res 2011b; 13: 215.10.1186/bcr2889Search in Google Scholar

Hosseini H, Li Y, Kanellakis P, Tay C, Cao A, Tipping P, Bobik A, Toh B-H, Kyaw T. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IGM producing b1a lymphocytes. Cardiovasc Res 2015; 106: 443–452.10.1093/cvr/cvv037Search in Google Scholar

Ishida T, Kiwada H. Accelerated blood clearance (ABC) phenomenon upon repeated injection of pegylated liposomes. Int J Pharm 2008; 354: 56–62.10.1016/j.ijpharm.2007.11.005Search in Google Scholar

Ishida T, Kiwada H. Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation. Google Patents, 2015.Search in Google Scholar

Jain AS, Goel PN, Shah SM, Dhawan VV, Nikam Y, Gude RP, Nagarsenker MS. Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation. Biomed Pharmacother 2014; 68: 429–438.10.1016/j.biopha.2014.03.004Search in Google Scholar

Ji X, Shi C, Qi L, Guo Y, Li N, Li Z, Luan Y. Preparation, properties and in vivo pharmacokinetic study of drug vesicles composed of diphenhydramine and AOT. RSC Adv 2014; 4: 62698–62707.10.1039/C4RA09294ESearch in Google Scholar

Jordheim LP, Durantel D, Zoulim F, Dumontet C. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat Rev Drug Discov 2013; 12: 447–464.10.1038/nrd4010Search in Google Scholar

Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science 2015; 348: 74–80.10.1126/science.aaa6204Search in Google Scholar

Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2: 133–140.10.1016/S1470-2045(00)00254-0Search in Google Scholar

Kirschfink M, Mollnes TE. Modern complement analysis. Clin Diagn Lab Immunol 2003; 10: 982–989.10.1128/CDLI.10.6.982-989.2003Search in Google Scholar

Koudelka S, Mikulik R, Mašek J, Raška M, Knotigová PT, Miller AD, Turánek J. Liposomal nanocarriers for plasminogen activators. J Control Release 2016; 227: 45–57.10.1016/j.jconrel.2016.02.019Search in Google Scholar

Kume Y, Maeda F, Harashima H, Kiwada H. Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system. J Pharmacol 1991; 43: 162–166.10.1111/j.2042-7158.1991.tb06658.xSearch in Google Scholar

Kuznetsova NR, Sevrin C, Lespineux D, Bovin NV, Vodovozova EL, Mészáros T, Szebeni J, Grandfils C. Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer. J Control Release 2012; 160: 394–400.10.1016/j.jconrel.2011.12.010Search in Google Scholar

Laing ST, Moody MR, Kim H, Smulevitz B, Huang S-L, Holland CK, McPherson DD, Klegerman ME. Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model. Thromb Res 2012; 130: 629–635.10.1016/j.thromres.2011.11.010Search in Google Scholar

Lee H-S, Lee NC, Kouprina N, Kim J-H, Kagansky A, Bates S, Trepel JB, Pommier Y, Sackett D, Larionov V. Effects of anticancer drugs on chromosome instability and new clinical implications for tumor-suppressing therapies. Cancer Res 2016; 76: 902–911.10.1158/0008-5472.CAN-15-1617Search in Google Scholar

Li R-J, Ying X, Zhang Y, Ju R-J, Wang X-X, Yao H-J, Men Y, Tian W, Yu Y, Zhang L. All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells. J Control Release 2011; 149: 281–291.10.1016/j.jconrel.2010.10.019Search in Google Scholar

Li S, Goins B, Zhang L, Bao A. Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjug Chem 2012; 23: 1322–1332.10.1021/bc300175dSearch in Google Scholar

Litster J. Stability of lipid bilayers and red blood cell membranes. Phys Lett A 1975; 53: 193–194.10.1016/0375-9601(75)90402-8Search in Google Scholar

Liu Z, Xiong M, Gong J, Zhang Y, Bai N, Luo Y, Li L, Wei Y, Liu Y, Tan X. Legumain protease-activated tat-liposome cargo for targeting tumours and their microenvironment. Nat Commun 2014; 5: 4280, DOI: 10.1038/ncomms5280.10.1038/ncomms5280Search in Google Scholar PubMed

Lodish H, Berk A, Zipursky S. Molecular Cell Biology, 4th ed., 2000.Search in Google Scholar

Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev 2013; 65: 1866–1879.10.1016/j.addr.2013.09.019Search in Google Scholar

Matthews JR, Payne CM, Hafner JH. Analysis of phospholipid bilayers on gold nanorods by plasmon resonance sensing and surface-enhanced raman scattering. Langmuir 2015; 31: 9893–9900.10.1021/acs.langmuir.5b01203Search in Google Scholar

McDougall SR, Anderson AR, Chaplain MA. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol 2006; 241: 564–589.10.1016/j.jtbi.2005.12.022Search in Google Scholar

Meng H, Wang M, Liu H, Liu X, Situ A, Wu B, Ji Z, Chang CH, Nel AE. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano 2015; 9: 3540–3557.10.1021/acsnano.5b00510Search in Google Scholar

Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (sln) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–177.10.1016/S0939-6411(00)00087-4Search in Google Scholar

Muthu MS, Agrawal P, Singh S. Theranostic nanomedicine of gold nanoclusters: an emerging platform for cancer diagnosis and therapy. Nanomedicine 2016; 11: 327–330.10.2217/nnm.15.198Search in Google Scholar PubMed

Nair PM, Flores H, Gogineni A, Marsters S, Lawrence DA, Kelley RF, Ngu H, Sagolla M, Komuves L, Bourgon R. Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display. Proc Natl Acad Sci U S A 2015; 112: 5679–5684.10.1073/pnas.1418962112Search in Google Scholar PubMed PubMed Central

Nguyen TX, Huang L, Gauthier M, Yang G, Wang Q. Recent advances in liposome surface modification for oral drug delivery. Nanomedicine 2016; 11: 1169–1185.10.2217/nnm.16.9Search in Google Scholar PubMed

Papagiannaros A, Dimas K, Papaioannou GT, Demetzos C. Doxorubicin-pamam dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. Int J Pharm 2005; 302: 29–38.10.1016/j.ijpharm.2005.05.039Search in Google Scholar PubMed

Park J-H, Cho H-J, Yoon HY, Yoon I-S, Ko S-H, Shim J-S, Cho J-H, Park JH, Kim K, Kwon IC. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J Control Release 2014; 174: 98–108.10.1016/j.jconrel.2013.11.016Search in Google Scholar PubMed

Perillo E, Porto S, Falanga A, Zappavigna S, Stiuso P, Tirino V, Desiderio V, Papaccio G, Galdiero M, Giordano A. Liposome armed with herpes virus-derived gh625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines. Oncotarget 2016; 7: 4077–4092.10.18632/oncotarget.6013Search in Google Scholar PubMed PubMed Central

Prado CM, Siervo M, Mire E, Heymsfield SB, Stephan BC, Broyles S, Smith SR, Wells JC, Katzmarzyk PT. A population-based approach to define body-composition phenotypes. Am J Clin Nutr 2014; 99: 1369–1377.10.3945/ajcn.113.078576Search in Google Scholar PubMed

Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: 1.10.1186/bcr2635Search in Google Scholar PubMed PubMed Central

Psarros C, Lee R, Antonopoulos A, Margaritis M, Antoniades C. Nanomedicine in cardiovascular disease. Nanotechnology and Drug Delivery, Volume 2: Nano-Engineering Strategies and Nanomedicines against Severe Diseases 2016; 257.Search in Google Scholar

Quach ND, Arnold RD, Cummings BS. Secretory phospholipase a2 enzymes as pharmacological targets for treatment of disease. Biochem Pharmacol 2014; 90: 338–348.10.1016/j.bcp.2014.05.022Search in Google Scholar PubMed PubMed Central

Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19: 1423–1437.10.1038/nm.3394Search in Google Scholar PubMed PubMed Central

Ramadass SK, Anantharaman NV, Subramanian S, Sivasubramanian S, Madhan B. Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of mda-mb-231 breast cancer cells. Colloids Surf B Biointerfaces 2015; 125: 65–72.10.1016/j.colsurfb.2014.11.005Search in Google Scholar PubMed

Rengan AK, Jagtap M, De A, Banerjee R, Srivastava R. Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photo-thermal therapy of breast cancer cells. Nanoscale 2014; 6: 916–923.10.1039/C3NR04448CSearch in Google Scholar PubMed

Rizzitelli S, Giustetto P, Faletto D, Castelli DD, Aime S, Terreno E. The release of doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model. J Control Release 2016; 230: 57–63.10.1016/j.jconrel.2016.03.040Search in Google Scholar PubMed

Roggers RA, Joglekar M, Valenstein JS, Trewyn BG. Mimicking red blood cell lipid membrane to enhance the hemocompatibility of large-pore mesoporous silica. ACS Appl Mater Interfaces 2014; 6: 1675–1681.10.1021/am4045713Search in Google Scholar PubMed

Ruan S, Qian J, Shen S, Chen J, Cun X, Zhu J, Jiang X, He Q, Gao H. Non-invasive imaging of breast cancer using RGDyK functionalized fluorescent carbonaceous nanospheres. RSC Adv 2015; 5: 25428–25436.10.1039/C5RA00099HSearch in Google Scholar

Sandor B, Marin M, Lapoumeroulie C, Rabaï M, Lefevre SD, Lemonne N, El Nemer W, Mozar A, Français O, Le Pioufle B. Effects of poloxamer 188 on red blood cell membrane properties in sickle cell anaemia. Br J Haematol 2016; 173: 145–149.10.1111/bjh.13937Search in Google Scholar

Sercombe L, Veerati T, Moheimani, F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol 2015; 6: 1–13.10.3389/fphar.2015.00286Search in Google Scholar

Schieren H, Rudolph S, Finkelstein M, Coleman P, Weissmann G. Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses. Biochim Biophys Acta 1978; 542: 137–153.10.1016/0304-4165(78)90240-4Search in Google Scholar

Sharma P, Banerjee R, Narayan KP. Mineralocorticoid receptor mediated liposomal delivery system for targeted induction of apoptosis in cancer cells. Biochim Biophys Acta Biomembranes 2016; 1858: 415–421.10.1016/j.bbamem.2015.11.023Search in Google Scholar

Shemesh CS, Hardy CW, David SY, Fernandez B, Zhang H. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells. Photodiagnosis Photodyn Ther 2014; 11: 193–203.10.1016/j.pdpdt.2014.02.001Search in Google Scholar

Shroff K, Kokkoli E. Pegylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells. Langmuir 2012; 28: 4729–4736.10.1021/la204466gSearch in Google Scholar

Shroff K, Liu D, Aravalli RN, Forster CL, Pengo T, Sanders MA, Ebbini ES, Kokkoli E. Design principles for peptide‐amphiphile‐induced liposomal receptor‐targeting with intracellular thermosensitivity. ChemNanoMat 2016; 2: 42–48.10.1002/cnma.201500138Search in Google Scholar

Sine J, Urban C, Thayer D, Charron H, Valim N, Tata DB, Schiff R, Blumenthal R, Joshi A, Puri A. Photoactivation of HPPH encapsulated in “pocket” liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts. Int J Nanomedicine 2015; 10: 125.Search in Google Scholar

Skibinski CG, Das A, Chen K-M, Liao J, Manni A, Kester M, El-Bayoumy K. A novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell lines. Chem Biol Interact 2016; 252: 1–8.10.1016/j.cbi.2016.03.035Search in Google Scholar

Song W-Y, Yang Q-L, Zhao W-L, Jin H-X, Yao G-D, Peng Z-F, Shi S-L, Yang H-Y, Zhang X-Y, Sun Y-P. The effects of anticancer drugs TSA and GSK on spermatogenesis in male mice. Am J Transl Res 2016; 8: 221.Search in Google Scholar

Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001; 70: 1–20.10.1016/S0168-3659(00)00339-4Search in Google Scholar

Spill F, Guerrero P, Alarcon T, Maini PK, Byrne HM. Mesoscopic and continuum modelling of angiogenesis. J Math Biol 2015; 70: 485–532.10.1007/s00285-014-0771-1Search in Google Scholar PubMed PubMed Central

Su Y-R, Yu S-H, Chao A-C, Wu J-Y, Lin Y-F, Lu K-Y, Mi F-L. Preparation and properties of pH-responsive, self-assembled colloidal nanoparticles from guanidine-containing polypeptide and chitosan for antibiotic delivery. Colloids Surf A Physicochem Eng Asp 2016; 494: 9–20.10.1016/j.colsurfa.2016.01.017Search in Google Scholar

Sun Y, Kim HS, Saw PE, Jon S, Moon WK. Targeted therapy for breast cancer stem cells by liposomal delivery of siRNA against fibronectin edb. Adv Healthc Mater 2015; 4: 1675–1680.10.1002/adhm.201500190Search in Google Scholar PubMed

Suzuki R, Omata D, Oda Y, Unga J, Negishi Y, Maruyama K. Cancer therapy with nanotechnology-based drug delivery systems: applications and challenges of liposome technologies for advanced cancer therapy. Nanomater Pharmacol 2016; 457–482.10.1007/978-1-4939-3121-7_23Search in Google Scholar

Szeto GL, Lavik EB. Materials design at the interface of nanoparticles and innate immunity. J Mater Chem B 2016; 4: 1610–1618.10.1039/C5TB01825KSearch in Google Scholar PubMed PubMed Central

Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 2013; 65: 157–170.10.1111/j.2042-7158.2012.01567.xSearch in Google Scholar PubMed

Tsai W-C, Rizvi SS. Liposomal microencapsulation using the conventional methods and novel supercritical fluid processes. Trends Food Sci Technol 2016; 55: 61–71.10.1016/j.tifs.2016.06.012Search in Google Scholar

Urbinati G, Marsaud V, Plassat V, Fattal E, Lesieur S, Renoir J-M. Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy. Int J Pharm 2010; 397: 184–193.10.1016/j.ijpharm.2010.06.046Search in Google Scholar PubMed

van den Bogaart G, Meyenberg K, Diederichsen U, Jahn R. Phosphatidylinositol 4,5-bisphosphate increases Ca2+ affinity of synaptotagmin-1 by 40-fold. J Biol Chem 2012; 287: 16447–16453.10.1074/jbc.M112.343418Search in Google Scholar PubMed PubMed Central

Vonarbourg A, Passirani C, Saulnier P, Benoit J-P. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006; 27: 4356–4373.10.1016/j.biomaterials.2006.03.039Search in Google Scholar PubMed

Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, Chang J. PLGA/polymeric liposome for targeted drug and gene co-delivery. Biomaterials 2010; 31: 8741–8748.10.1016/j.biomaterials.2010.07.082Search in Google Scholar PubMed

Wang Z, Yu Y, Dai W, Lu J, Cui J, Wu H, Yuan L, Zhang H, Wang X, Wang J. The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer. Biomaterials 2012; 33: 8451–8460.10.1016/j.biomaterials.2012.08.031Search in Google Scholar PubMed

Wong M-Y, Chiu GN. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine 2011; 7: 834–840.10.1016/j.nano.2011.02.001Search in Google Scholar PubMed

Yeung M, Ding Q, Brooks C, Xiao S, Workman C, Vignali D, Ueno T, Padera R, Kuchroo V, Najafian N. Tim‐1 signaling is required for maintenance and induction of regulatory B cells. Am J Transplant 2015; 15: 942–953.10.1111/ajt.13087Search in Google Scholar PubMed PubMed Central

Yoshida A, Shigekuni M, Tanabe K, Fujita A. Nanoscale analysis reveals agonist-sensitive and heterogeneous pools of phosphatidylinositol 4-phosphate in the plasma membrane. Biochim Biophys Acta Biomembranes 2016; 1858: 1298–1305.10.1016/j.bbamem.2016.03.011Search in Google Scholar PubMed

Yue X, Dai Z. Multifunctional liposomes for imaging-guided therapy. Advances in Nanotheranostics I. Springer, 2016; 301–336.10.1007/978-3-662-48544-6_10Search in Google Scholar

Zahmatkeshan M, Gheybi F, Rezayat SM, Jaafari MR. Improved drug delivery and therapeutic efficacy of pegylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model. Eur J Pharm Sci 2016; 86: 125–135.10.1016/j.ejps.2016.03.009Search in Google Scholar PubMed

Zhang G-S, Hu P-Y, Li D-X, He M-Z, Rao X-Y, Luo X-J, Wang Y-S, Wang Y-R. Formulations, hemolytic and pharmacokinetic studies on saikosaponin A and saikosaponin D compound liposomes. Molecules 2015; 20: 5889–5907.10.3390/molecules20045889Search in Google Scholar PubMed PubMed Central

Zhou Y, Wong C-O, Cho K-J, Van Der Hoeven D, Liang H, Thakur DP, Luo J, Babic M, Zinsmaier KE, Zhu MX. Membrane potential modulates plasma membrane phospholipid dynamics and k-ras signaling. Science 2015; 349: 873–876.10.1126/science.aaa5619Search in Google Scholar PubMed PubMed Central

Zlatev HP, Auriola S, Mönkkönen J, Määttä JA. Uptake of free, calcium-bound and liposomal encapsulated nitrogen containing bisphosphonates by breast cancer cells. Eur J Pharm Sci 2016; 86: 58–66.10.1016/j.ejps.2016.02.016Search in Google Scholar PubMed